Feline Osteoarthritis Treatment Market: By Drug Class, (Nutraceuticals, Pharmaceuticals) By Formulation Type, (Oral tablets, Oral gels) By Distribution Channel, (Veterinary pharmacies, Retail pharmacies, Online pharmacies), and Geography    

Purchase Option

$ 4400
$ 6600
$ 8900

Feline Osteoarthritis Treatment Market size was valued at USD 492.3 million in 2022 and is anticipated to grow at a CAGR of 5.1% over 2023-2029. Feline osteoarthritis, often simply referred to as arthritis in cats, is a common degenerative joint disease that affects the joints and cartilage in a cat's body. This condition is relatively common in older cats but can also occur in younger ones due to factors like genetics, injury, or infection. Feline osteoarthritis treatment aims to manage pain and improve the cat's quality of life. The rising feline population plays a pivotal role in driving the revenues of the feline osteoarthritis treatment market. With the global increase in the pet cat population, cases of feline osteoarthritis have risen, resulting in a higher demand for effective treatments like medication and therapy. As pet owners become more proactive in seeking solutions to improve the quality of life for their feline companions, the market experiences steady growth in response to this rising demographic trend.

Moreover, the aging feline population is a significant driver behind the growth of the feline osteoarthritis treatment market. As cats age, they become more susceptible to osteoarthritis, a degenerative joint disease that causes pain and mobility issues. With many cat owners considering their pets as part of the family, there is a growing emphasis on providing them with a comfortable and pain-free life in their senior years. This has led to increased awareness and diagnosis of feline osteoarthritis cases, driving the demand for effective treatment options. However, stringent regulatory policies for the approval of veterinary medicines, complexity in early-stage disease diagnosis, less number of treatment options in the market, and lack of awareness about the disease in rural areas are the factors restraining the growth of the feline osteoarthritis management market. Meanwhile, ongoing clinical trials for feline osteoarthritis treatment create significant opportunities for the growth of the feline osteoarthritis treatment market. Key market players are developing innovative treatment solutions that further contribute to the feline osteoarthritis treatment market’s growth. For instance, in January 2022, Zoetis announced the approval of the first and only injectable monoclonal antibody (mAb), Solensia by the FDA to control osteoarthritis pain in cats.

Feline Osteoarthritis Treatment Market Key Developments:

In October 2021, Scout Bio initiated Multi-Center Clinical Study of company’s one-time AAV gene therapy, SB-007, for chronic arthritis pain in cats.

Feline Osteoarthritis Treatment Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

5.1%

Largest Market

North America

Fastest Growing Market

North America
Feline Osteoarthritis Treatment Market Dynamics

Increase in the prevalence of obesity in felines, lack of nutritional feed, increase in the R&D activities for the innovation of newer drugs for feline arthritis, and rise in feline adoption rate are anticipated to fuel the feline osteoarthritis management market. Moreover, ongoing clinical trials for feline osteoarthritis treatment, rise in animal welfare expenditure, and increase in the number of elder cats (cats with more than 7 years are more prone to osteoarthritis disease) are expected to propel the feline osteoarthritis treatment market over the forecast period. However, stringent regulatory policies for the approval of veterinary medicines, complexity in early-stage disease diagnosis, less number of treatment options in the market, and lack of awareness about the disease in rural areas are the factors restraining the growth of feline osteoarthritis management market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Feline Osteoarthritis Treatment Market Segmentation

By Drug Class
  • Nutraceuticals
    • Glucosamine
    • Chondroitin
  • Pharmaceuticals
    • Butorphanol
    • Buffered Aspirin
    • Corticosteroids
    • Tramadol
    • Others
By Formulation Type
  • Oral tablets
  • Oral gels
By Distribution Channel
  • Veterinary pharmacies
  • Retail pharmacies
  • Online pharmacies
By Geography
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Frequently Asked Questions

The feline osteoarthritis treatment market size was valued at USD 492.3 million in 2022

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

The feline osteoarthritis treatment market key players are Zoetis Inc. (U.S.), Bayer Animal Health (Germany), Nutramax Laboratories (U.S.), Doctors. Foster and Smith (U.S.), VetriScience Laboratories (U.S.), Garmon Corp. (U.S.)

1.Executive Summary
2.Global Feline Osteoarthritis Treatment Market Introduction 
2.1.Global Feline Osteoarthritis Treatment Market  - Taxonomy
2.2.Global Feline Osteoarthritis Treatment Market  - Definitions
2.2.1.Drug Class
2.2.2.Formulation Type
2.2.3.Distribution Channel
2.2.4.Region
3.Global Feline Osteoarthritis Treatment Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Feline Osteoarthritis Treatment Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Feline Osteoarthritis Treatment Market  By Drug Class, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Nutraceuticals
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Pharmaceuticals
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
6.Global Feline Osteoarthritis Treatment Market  By Formulation Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Oral tablets
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Oral gels
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
7.Global Feline Osteoarthritis Treatment Market  By Distribution Channel, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. Veterinary pharmacies
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Retail pharmacies
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Online pharmacies
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.Global Feline Osteoarthritis Treatment Market  By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Feline Osteoarthritis Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. Drug Class Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Nutraceuticals
9.1.2.Pharmaceuticals
9.2.  Formulation Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Oral tablets
9.2.2.Oral gels
9.3.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Veterinary pharmacies
9.3.2.Retail pharmacies
9.3.3.Online pharmacies
9.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Feline Osteoarthritis Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Drug Class Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Nutraceuticals
10.1.2.Pharmaceuticals
10.2.  Formulation Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Oral tablets
10.2.2.Oral gels
10.3.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Veterinary pharmacies
10.3.2.Retail pharmacies
10.3.3.Online pharmacies
10.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
11.Asia Pacific (APAC) Feline Osteoarthritis Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1. Drug Class Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Nutraceuticals
11.1.2.Pharmaceuticals
11.2.  Formulation Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Oral tablets
11.2.2.Oral gels
11.3.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Veterinary pharmacies
11.3.2.Retail pharmacies
11.3.3.Online pharmacies
11.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Feline Osteoarthritis Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Drug Class Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Nutraceuticals
12.1.2.Pharmaceuticals
12.2.  Formulation Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Oral tablets
12.2.2.Oral gels
12.3.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Veterinary pharmacies
12.3.2.Retail pharmacies
12.3.3.Online pharmacies
12.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Feline Osteoarthritis Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
13.1. Drug Class Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Nutraceuticals
13.1.2.Pharmaceuticals
13.2.  Formulation Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Oral tablets
13.2.2.Oral gels
13.3.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Veterinary pharmacies
13.3.2.Retail pharmacies
13.3.3.Online pharmacies
13.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Zoetis Inc. (U.S.)
14.2.2.Bayer Animal Health (Germany)
14.2.3.Nutramax Laboratories (U.S.)
14.2.4.Doctors. Foster and Smith (U.S.)
14.2.5.VetriScience Laboratories (U.S.)
14.2.6.Garmon Corp. (U.S.)
15. Research Methodology 
16. Appendix and Abbreviations 
  • Zoetis Inc. (U.S.)
  • Bayer Animal Health (Germany)
  • Nutramax Laboratories (U.S.)
  • Doctors. Foster and Smith (U.S.)
  • VetriScience Laboratories (U.S.)
  • Garmon Corp. (U.S.)

Adjacent Markets